The U.S. Meals and Drug Administration (FDA) has granted breakthrough remedy designation to sofetabart mipitecan for grownup sufferers with platinum-resistant epithelial ovarian,...
The U.S. Meals and Drug Administration (FDA) has accepted Guardant360 CDx as a companion diagnostic to determine sufferers with BRAF V600E-mutant metastatic...
Trendy a number of myeloma therapy usually entails complicated mixture therapies, which considerably impression day by day life for sufferers and care...
